secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001104659-23-117704
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics appoints Brent Pfeiffenberger as President and CEO, effective Dec 4, 2023
--------------------------------------------------------------------------------

- Brent Pfeiffenberger appointed CEO and to Board; Gregory Russotti transitions to Chief Technology and Manufacturing Officer.
- Pfeiffenberger receives $625K base salary, 55% target bonus, $200K signing bonus, $450K retention bonus, and equity awards.
- Equity includes options for 573,691 shares and RSUs covering 1,173,775 shares (Initial RSU) plus $450K value Second RSU.
- Russotti's new role carries $525K base salary and 45% annual target bonus; prior interim CEO role ends Dec 4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465923117704/0001104659-23-117704-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465923117704/tm2330591d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-117704

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer